Condition: Trouble obsessionnel-compulsif

What It Is

Obsessive-compulsive disorder pairs two symptoms that reinforce each other. Obsessions are unwanted thoughts, images, or urges that arrive on their own and set off intense anxiety or disgust. They take many shapes. Someone may fear contamination, dread having made a careless mistake, need things to be even or exact, or suffer an intrusive thought about harm, sex, or blasphemy. Compulsions are the acts done to make that feeling go away: washing, checking, counting, arranging, or a private mental ritual like repeating a phrase or reviewing an event. The relief is real but brief, so the cycle runs again, and it grows.

Everyone double-checks a lock or a stove sometimes. What marks the disorder is how much of the day it takes and what it costs. The usual threshold is more than an hour a day, or symptoms that clearly interfere with work, study, relationships, or ordinary routine. Clinicians measure the severity with the Yale-Brown Obsessive-Compulsive Scale, the Y-BOCS. It rates how much time the obsessions and compulsions take, how much distress they cause, and how hard they are to resist.

OCD affects roughly one in forty people over a lifetime, and milder obsessive or compulsive symptoms are far more common than the full disorder. It usually starts in childhood, adolescence, or early adulthood, and it often travels with depression, other anxiety disorders, or tics. Insight varies: many people know the fear is out of proportion and cannot stop anyway, and some are more convinced the danger is real.

Intrusive thoughts about harming a child, about violence, or about an unwanted sexual or religious theme are a recognized and common form of OCD. The distress comes exactly because these thoughts offend the person's own values. A thought like this carries no wish to act, and having one does not make a person likely to act on it. The distress, the checking, and the reassurance-seeking are the disorder; the thought itself is only a symptom.

The distress comes exactly because these thoughts offend the person's own values. A thought like this carries no wish to act, and having one does not make a person likely to act on it.

Two habits keep OCD going once it starts. One is avoidance: steering around whatever triggers the obsession. The other is reassurance-seeking: asking others to confirm that nothing bad happened or will. Both bring a moment of relief. Both teach the brain that the ritual was necessary, which is why the treatments that work all involve doing the opposite.

What Helps

OCD is treatable. The two first-line treatments are a specific form of talking therapy and the serotonin-based antidepressants, and they combine well.

Exposure and response prevention forms the active, OCD-specific arm of cognitive behavioral therapy. You approach the feared thing in graded, repeated steps: touching the doorknob, leaving the stove unchecked, allowing the intrusive thought. Then you hold off the ritual that would neutralize it and let the anxiety rise and fall on its own. Over sessions the fear response weakens and the compulsion fades. It is work, and it is the most effective single treatment there is.

Medication is the other first-line path. The SSRIs are effective for OCD, usually at higher doses and over a longer trial, ten to twelve weeks, than depression needs. The older drug clomipramine works about as well and is sometimes numerically stronger, but its side effects mean the SSRIs are tried first. Therapy and medication can be combined, and for many people the combination beats either alone.

In children and teenagers, therapy leads. Exposure-based CBT alone and CBT combined with an SSRI both outperformed the medication on its own. Treatment usually starts with therapy and adds medication for more severe cases.

For OCD that has not responded to an adequate SSRI trial, there are several next steps. Adding exposure and response prevention to the medication is one of the most effective, and in a head-to-head trial it beat adding a drug. Adding a low dose of certain antipsychotics, risperidone or aripiprazole, helps about a third of hard-to-treat cases. Deep transcranial magnetic stimulation is a non-invasive brain stimulation, cleared by the FDA for OCD in 2018. It produced a response in some people for whom medication and therapy had already failed. For the small number with severe, disabling OCD that resists all of this, specialist centers offer further options that a doctor's referral opens up.

The supplements marketed for OCD have thin, mixed evidence. N-acetylcysteine has been tested in several small trials with mixed and mostly negative results. Myo-inositol rests on a single crossover trial of thirteen people, and a later add-on trial found no benefit. Neither is established, and neither replaces the treatments above. Someone can try one alongside proper treatment at low safety risk.

One of the highest-return moves does not involve the person with OCD at all. When family members join in the rituals, they give reassurance, wait for a check to finish, buy extra cleaning supplies, or reorganize the home around a fear. This is called family accommodation. The more of it there is, the worse OCD gets and the harder it is to treat. Stepping back from that accommodation, done as a calm and agreed change, is part of the treatment. For children, a program that coaches parents to do exactly this worked about as well as sending the child to therapy.

The Research & Studies

Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.

Anxiety And Stress

Exposure and response prevention beat placebo conditions by a very large margin, Hedges g about 1.3Strong

In plain terms

The OCD-specific talking therapy, where you face the fear and hold off the ritual, works far better than a dummy treatment, and somewhat better than medication alone.

In detail

In a meta-analysis of 37 randomized trials scored on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), exposure and response prevention and the other cognitive behavioral treatments for OCD beat waiting lists (Hedges g 1.31) and placebo conditions (g 1.33), both very large effects. Exposure and response prevention and cognitive therapy did not differ from each other (g 0.07), and individual and group formats were similar (g 0.17). CBT was also better than antidepressant medication (g 0.55). Measured in: 37 randomized controlled trials of cognitive behavioral treatment for OCD using the interviewer-rated Y-BOCS, published 1993 to 2014. The very large numbers come from comparisons against waiting lists and placebo conditions; the gap over active medication is smaller (g 0.55), and trials enroll people willing to attempt exposure, who may respond better than those who refuse it.

Who this may not transfer to:Adult OCD samples are roughly balanced by sex; individual trials did not consistently report a breakdown.

The study · 1

Ost et al., cognitive behavioral treatments of obsessive-compulsive disorder, a systematic review and meta-analysis of studies published 1993-2014 · Clin Psychol Rev 2015

Psychotherapy alone or combined with medication outperformed medication alone for OCDStrong

In plain terms

Comparing every OCD treatment against each other at once, therapy did as well as or better than drugs, and combining therapy with medication did best.

In detail

A network meta-analysis of 53 randomized trials in adults found SSRIs, clomipramine, and the cognitive behavioral therapies (behavioral, cognitive, and combined) all beat placebo on the Y-BOCS, and that psychological therapy alone, or combined with an SSRI, produced larger improvements than medication alone. Clomipramine ranked among the most effective drugs but carries more side effects than the SSRIs. Measured in: 53 randomized controlled trials of pharmacological and psychotherapeutic treatments in adults with OCD. Many psychotherapy trials were small and could not blind participants, which tends to inflate the therapy estimates, and the analysis pooled different SSRIs and CBT formats together.

Who this may not transfer to:Adult trials, roughly balanced by sex; per-trial breakdowns not uniformly reported.

The study · 1

Skapinakis et al., pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults, a systematic review and network meta-analysis · Lancet Psychiatry 2016

SSRIs roughly doubled the chance of treatment response versus placeboStrong

In plain terms

The antidepressants used for OCD help more people than a placebo pill, about double the response rate.

In detail

A Cochrane review of 17 placebo-controlled trials with 3,097 adults found SSRIs as a class reduced OCD symptoms more than placebo between 6 and 13 weeks, with about twice the odds of a clinical response and a weighted mean difference of roughly 3.2 points on the Y-BOCS. Individual SSRIs did not clearly differ from one another, so the choice comes down to side effects and drug interactions. Measured in: 17 randomized placebo-controlled trials, 3,097 adults with OCD. Response is partial for most: symptoms drop by roughly a quarter to a third on average, not to zero, and the benefit takes several weeks and often needs higher doses than for depression.

Who this may not transfer to:Adult OCD trials, roughly balanced by sex; breakdown not reported per trial.

The study · 1

Soomro et al., selective serotonin re-uptake inhibitors versus placebo for obsessive compulsive disorder, Cochrane systematic review · Cochrane Database Syst Rev 2008

Chez les enfants, la TCC a atteint la rémission chez 39 % et la TCC associée à la sertraline chez 54 %, contre 21 % pour la sertraline seuleStrong

In plain terms

Chez les enfants atteints de TOC, la thérapie par exposition a mieux fonctionné que le médicament seul, et la combinaison des deux a été la plus efficace.

In detail

Dans l'étude Pediatric OCD Treatment Study, 112 enfants et adolescents ont été randomisés pour recevoir une thérapie cognitivo-comportementale, de la sertraline, les deux, ou un placebo pendant 12 semaines. La rémission clinique a atteint 53.6 % avec la combinaison, 39.3 % avec la TCC seule, 21.4 % avec la sertraline seule et 3.6 % avec le placebo. La combinaison et la TCC seule ont toutes deux surpassé la sertraline seule, ce qui explique pourquoi les recommandations préconisent de débuter les enfants par une thérapie basée sur l'exposition et d'ajouter un médicament pour les cas plus sévères. Measured in: 112 children and adolescents aged 7 to 17 with OCD. Il s'agissait d'un essai d'efficacité de 12 semaines ; la rémission était définie par un score de symptômes faible, et l'effet de la TCC différait selon les sites, ce qui suggère que la qualité de la thérapie compte.

Who this may not transfer to:Children and adolescents of both sexes; boys somewhat over-represented, as is typical in pediatric OCD.

The study · 1

Pediatric OCD Treatment Study (POTS) Team, cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder, a randomized controlled trial · JAMA 2004

Higher SSRI doses worked better for OCD than low or medium dosesModerate

In plain terms

OCD usually needs a bigger dose of the antidepressant than depression does, and the bigger dose works somewhat better.

In detail

A meta-analysis of 9 trials with 2,268 patients found higher SSRI doses produced greater improvement on the Y-BOCS and more treatment responders than low or medium doses, though the higher doses also caused more dropout from side effects. This is a main reason OCD is often treated at doses above those used for depression. Measured in: 9 randomized dose-comparison trials, 2,268 patients with OCD. The extra benefit is modest and comes with more side effects and dropout, so the dose is raised gradually and balanced against tolerability, not pushed to the maximum for everyone.

Who this may not transfer to:Adult OCD trials, roughly balanced by sex; breakdown not reported.

The study · 1

Bloch et al., meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder · Mol Psychiatry 2010

Adding exposure therapy to an SSRI beat adding an antipsychoticModerate

In plain terms

When an antidepressant was not enough, adding exposure therapy helped more than adding an antipsychotic drug.

In detail

In a randomized trial of 100 adults still symptomatic on a therapeutic SSRI dose, adding 17 sessions of exposure and response prevention lowered Y-BOCS scores far more than adding risperidone or placebo: the exposure group improved by roughly 10 points, versus about 4 for risperidone, which did not beat placebo. The exposure group's advantage held at six months. Measured in: 100 adults with OCD still symptomatic on an SSRI, randomized to added exposure and response prevention, risperidone, or placebo. This was a single trial at academic centers with therapists trained in exposure, which is not available everywhere; risperidone was dosed conservatively.

Who this may not transfer to:Adult OCD sample, both sexes; breakdown not separately analyzed here.

The study · 1

Simpson et al., cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder, a randomized clinical trial · JAMA Psychiatry 2013

Adding a low-dose antipsychotic helped about one in three whose OCD resisted an SSRIModerate

In plain terms

For OCD that does not respond to an antidepressant, adding a small dose of certain antipsychotics helps about one in three people.

In detail

A meta-analysis of double-blind trials in people whose OCD had not responded to an adequate SSRI or clomipramine trial found that adding low-dose risperidone or aripiprazole improved Y-BOCS scores more than placebo, with roughly a third of these treatment-resistant patients responding. Quetiapine and olanzapine did not show a clear benefit. Measured in: Double-blind randomized trials of atypical antipsychotic augmentation in adults with SSRI-resistant OCD. This is add-on treatment for resistant cases only, the responders are a minority, and antipsychotics carry their own side effects, including weight gain and metabolic changes, so they are used with monitoring.

Who this may not transfer to:Adult treatment-resistant OCD samples, both sexes; breakdown not pooled.

The study · 1

Veale et al., atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder, a systematic review and meta-analysis · BMC Psychiatry 2014

La TMS profonde a produit une réponse chez 38 % des patients contre 11 % sous placeboModerate

In plain terms

Un traitement par stimulation magnétique du cerveau a aidé environ 38 personnes sur 100 atteintes de TOC difficile à traiter, contre 11 sur 100 ayant reçu une version factice.

In detail

Dans l'essai multicentrique à l'origine de l'homologation FDA de 2018, 99 adultes atteints de TOC n'ayant pas suffisamment répondu aux médicaments ou à la thérapie ont reçu une stimulation magnétique transcrânienne profonde à haute fréquence ou une procédure factice sur le cortex préfrontal médian et le cortex cingulaire antérieur, après une exposition provoquant les symptômes, pendant environ six semaines. Une réponse significative, définie comme une baisse d'au moins 30 % au Y-BOCS, est survenue chez 38.1 % des patients sous traitement actif contre 11.1 % sous placebo, et l'écart s'est maintenu un mois plus tard. Measured in: 99 adults with OCD inadequately responsive to standard treatment, randomized to active or sham deep TMS at 11 centers. Cela n'a été étudié que comme traitement d'appoint chez des personnes déjà en échec du traitement standard, le seuil de réponse (une baisse de 30 % des symptômes) laisse encore des symptômes importants, et il nécessite des visites en clinique presque quotidiennes pendant environ six semaines.

Who this may not transfer to:Adult OCD sample, both sexes; breakdown not separately analyzed.

The study · 1

Carmi et al., efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder, a prospective multicenter randomized double-blind placebo-controlled trial · Am J Psychiatry 2019;176(11):931-938

L'accommodation familiale des rituels était associée à une sévérité accrue du TOC, corrélation d'environ 0.42Moderate · risk

In plain terms

Plus une famille participe aux rituels ou s'organise autour d'eux, plus le TOC a tendance à être sévère.

In detail

Sur 41 études, le degré auquel les membres de la famille participaient aux rituels d'une personne ou les facilitaient, en donnant des réassurances, en attendant la fin des rituels et en modifiant les routines familiales, était modérément corrélé à la sévérité des symptômes du TOC (r d'environ 0.42) et était associé à une moins bonne réponse au traitement et à une altération fonctionnelle plus importante. Measured in: 41 studies of family accommodation and OCD symptom severity in children and adults. What could explain it instead: reverse causation, since more severe OCD demands more accommodation from family, inflating the association independent of any causal effect of accommodation. Il s'agit d'une relation corrélationnelle, donc la flèche va dans les deux sens : un TOC plus sévère entraîne davantage d'accommodation de la part de la famille, tout comme l'accommodation aggrave le TOC.

Who this may not transfer to:Combined child and adult samples, both sexes.

The study · 1

Wu et al., a meta-analysis of family accommodation and OCD symptom severity · Clin Psychol Rev 2016

Un programme destiné uniquement aux parents et réduisant l'accommodation a égalé la thérapie de l'enfantModerate

In plain terms

Apprendre aux parents à cesser de s'organiser autour de la peur a aidé les enfants presque autant qu'une consultation de l'enfant chez un thérapeute.

In detail

Dans un essai randomisé de non-infériorité portant sur 124 enfants atteints de troubles anxieux, dont le TOC, un traitement centré sur les parents (SPACE) qui coachait les parents pour qu'ils cessent d'accommoder et soutiennent l'enfant s'est révélé non inférieur à la thérapie cognitivo-comportementale individuelle de l'enfant sur des critères évalués par des évaluateurs indépendants, et a réduit l'accommodation familiale davantage que la thérapie de l'enfant. L'enfant n'a jamais eu à assister à une séance. Measured in: 124 children aged 7 to 14 with primary anxiety disorders including OCD; 53% girls. L'échantillon était composé majoritairement de troubles anxieux avec le TOC comme sous-groupe, et à 83 % de personnes blanches, et le traitement cible le comportement de la famille et non l'enfant directement, ce qui le rend adapté aux enfants qui refusent la thérapie plutôt que généralisable aux adultes.

Who this may not transfer to:Children of both sexes, 53% girls.

The study · 1

Lebowitz et al., parent-based treatment as efficacious as cognitive-behavioral therapy for childhood anxiety, a randomized noninferiority study of Supportive Parenting for Anxious Childhood Emotions (SPACE) · J Am Acad Child Adolesc Psychiatry 2020

Environ 1 personne sur 40 est atteinte de TOC à un moment de sa vie, soit un taux vie entière de 2.3 %Moderate · mixed

In plain terms

Le TOC touche environ une personne sur quarante au cours de sa vie, et des symptômes obsessionnels ou compulsifs plus légers sont bien plus fréquents.

In detail

Dans la National Comorbidity Survey Replication américaine, la prévalence vie entière du TOC était de 2.3 % et la prévalence sur la dernière année de 1.2 %, tandis que plus d'un quart des personnes ont rapporté des obsessions ou compulsions à un moment donné n'atteignant pas le seuil diagnostique complet. La plupart des cas ont débuté dans l'enfance ou l'adolescence, et le TOC présentait une forte comorbidité avec d'autres troubles anxieux, de l'humeur et du contrôle des impulsions. Measured in: 9,282 US adults in a nationally representative household survey. What could explain it instead: case ascertainment by lay-administered structured interview may over- or under-count clinical OCD relative to a clinician assessment, shifting the prevalence estimate. Les diagnostics provenaient d'un entretien structuré mené par des non-cliniciens formés, ce qui peut classer certains cas limites différemment de ce que ferait un clinicien.

Who this may not transfer to:Nationally representative adult sample, both sexes.

The study · 1

Ruscio et al., the epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication · Mol Psychiatry 2010

Le myo-inositol a surpassé le placebo dans un petit essai croisé de 13 personnesPreliminary

In plain terms

Un complément apparenté au sucre, le myo-inositol, a aidé dans une très petite étude sur le TOC, mais n'a rien apporté lorsqu'il était ajouté à un traitement médicamenteux standard.

In detail

Dans un essai croisé en double aveugle, 13 adultes atteints de TOC ont pris 18 grammes de myo-inositol par jour pendant six semaines et ont obtenu des scores Y-BOCS plus bas que sous placebo. Un essai ultérieur ajoutant le myo-inositol aux inhibiteurs de la recapture de la sérotonine dans le TOC résistant au traitement n'a trouvé aucun bénéfice supplémentaire. Measured in: 13 adults with OCD in a double-blind placebo-controlled crossover trial. Treize personnes, c'est bien trop peu pour s'y fier, la dose étudiée d'environ 18 grammes par jour provoque couramment des selles molles et des nausées, et l'essai de suivi en association s'est révélé négatif.

Who this may not transfer to:Small adult sample of both sexes; too small for a meaningful sex analysis.

The study · 1

Fux et al., inositol treatment of obsessive-compulsive disorder, a double-blind crossover trial · Am J Psychiatry 1996

How It Works

OCD combines a brain loop and a learning trap. The loop connects the front of the brain to deeper structures, the cortico-striato-thalamo-cortical circuit. It normally flags something as wrong, then the alarm switches off once the problem is handled. In OCD the alarm keeps firing: the sense that something is wrong, dirty, unsafe, or unfinished does not clear, so the mind keeps returning to it.

The learning trap turns that alarm into a disorder. An obsession raises anxiety, and the compulsion lowers it. The fast relief acts as a reward, so the brain learns that the ritual is what kept the danger away. Each repetition strengthens the link, and the obsession does not weaken on its own. Reassurance and family accommodation feed the same loop from the outside. They are compulsions carried out by proxy, and they teach the same lesson.

Exposure and response prevention reverses the trap directly. By approaching the trigger and holding off the ritual, the person learns that the feared outcome does not come, or that the anxiety subsides on its own. The obsession then weakens. Psychologists describe this as new learning that inhibits the old fear. The SSRIs and clomipramine reach the same circuit by a different route. They raise the availability of serotonin, and over weeks that lowers the reactivity of the loop. The slow onset and higher doses match a change that builds up over those weeks.

Go Deeper

• Anxiety: the family OCD sits closest to, with the same exposure-based therapy at its core and a large overlap in treatment.
• Depression: the condition OCD most often travels with, and the overlapping medications.
• Cognitive behavioral therapy: the broader therapy whose OCD-specific arm is exposure and response prevention.
• Meditation: a mind-body practice studied as an adjunct for anxiety and rumination, at the strength the trials found.
• Slow breathing and heart-rate variability: a way to lower baseline arousal, useful as a support alongside treatment.

The Chinese Medicine View

Chinese medicine has no category that matches obsessive-compulsive disorder. It reads the picture as several distinct patterns of the mind and the organs. In this tradition the Heart houses the Shen, the conscious mind and spirit. The Spleen governs sustained thinking and worry, called si. The Gallbladder governs decisiveness and courage, so a practitioner reads timidity, indecision, and being easily startled as a Gallbladder sign. Obsessive rumination is most often understood as overthinking that depletes the Spleen and unsettles the Shen, sometimes with Phlegm obstructing the mind.

The Chinese Medicine View

The patterns below are common readings of obsessive worry and compulsion. Naming the pattern points toward a different treatment. A practitioner asks about sleep, digestion, appetite, and the tongue before choosing anything. None of these is a substitute for exposure and response prevention or medication.

Heart and Spleen deficiency

Rumination that will not stop, worry that goes in circles, poor appetite, fatigue that rest does not fix, palpitations, poor memory, and broken sleep, with a pale tongue. Attributed to prolonged overthinking depleting the Spleen and leaving too little Blood to settle the Shen. Gui Pi Tang is the classical direction.

Heart and Gallbladder deficiency

Timidity, indecision, being easily startled, a constant sense that something is about to go wrong, and the checking and reassurance-seeking that follow from it. The Gallbladder governs decision and courage, so it appears in a pattern about doubt and fright. An Shen Ding Zhi Wan is a reference direction.

Phlegm clouding the mind

Thoughts that turn sticky and fixed, a heavy or foggy head, a thick greasy tongue coating, nausea or a sense of fullness, and restless dreams. Rich food and alcohol are often in the picture. Points toward transforming Phlegm and opening the orifices, with Wen Dan Tang a classical base.

Liver qi constraint turning to heat

Tension across the chest and ribs, irritability, a sense of pressure that will not release, a quicker temper, and disturbed sleep, often worse under stress. Points toward moving the constraint and clearing heat, the territory of Xiao Yao San and its cooling variants.

Within its own frame, Chinese medicine treats these pictures with acupuncture and herbal formulas chosen for the pattern. A practitioner would first build up a depleted person. The qi-moving formulas that suit a tense, constrained person can wear out someone who is already depleted. The modern trial evidence for acupuncture and Chinese herbs in OCD specifically is sparse and of low quality. On its own terms, the tradition is a considered adjunct held alongside evidence-based care, and a practitioner works within it while standard treatment continues. Any herbs belong with a practitioner and a traceable supply. The formulas differ from person to person, and herbal products can interact with the antidepressants used for OCD.

Cautions

Extra restraint

Everything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.

OCD needs higher doses and a longer trial than depression

The SSRIs used for OCD usually work at higher doses and take longer to show, often ten to twelve weeks at a full dose before the benefit is clear. This matters because people sometimes stop too early or at too low a dose and conclude the medicine failed. The dose is raised gradually and weighed against side effects with a prescriber.

Do not stop an antidepressant abruptly

Stopping an SSRI or clomipramine suddenly, or missing several doses, commonly brings dizziness, electric-shock sensations, nausea, flu-like feelings, and vivid dreams. These are not a sign of addiction, and they are largely avoidable: a prescriber can taper the dose down slowly. If a medication is no longer wanted, plan the change with a prescriber.

Combining serotonin-raising drugs

Clomipramine and the SSRIs raise serotonin, and combining them with each other, with tramadol, triptans, linezolid, or St John's wort can rarely push serotonin activity too high. Agitation, confusion, a fast heart, sweating, tremor, and twitching muscles within hours of a change are the warning signs, and it is a same-day emergency. Every new combination is worth clearing with a prescriber or pharmacist first.

Antipsychotic augmentation is monitored

When a low-dose antipsychotic such as risperidone or aripiprazole is added for resistant OCD, it helps a minority. It carries its own side effects, including weight gain, sedation, and metabolic changes. It is used as an add-on for resistant cases with monitoring, and it is reviewed and stopped if it is not helping.

Supplements are not a treatment here

N-acetylcysteine and myo-inositol are low-risk but weakly supported, and neither substitutes for exposure therapy or medication when OCD is disrupting a life. Myo-inositol at the studied dose, around 18 grams a day, commonly causes loose stools and nausea. If either is used, it is alongside proper treatment, not instead of it.

OCD is common and treatable, and most of it is safe to work on with a therapist or a prescriber. A few specific situations need extra care. Talk to a doctor or pharmacist if any apply to you, and see the warning signs below for what needs help sooner.

When to See Someone

OCD is treatable, and a few of the signs below need help sooner. If you are thinking about suicide or about harming yourself, treat it as a medical emergency: call your local emergency number, go to an emergency department, or call the suicide and crisis line your own country's health service publishes. If someone is with you, ask them to stay. Asking someone directly whether they are thinking of ending their life does not put the idea there.

• Thoughts of harming yourself or ending your life, a suicide attempt, or a new plan or intention to act. OCD raises the risk of suicidal thinking. Contact your local emergency services or the crisis line your health service lists.(seek urgent care)
• An intention or urge you feel you might act on to harm yourself or someone else. This is different from the intrusive, unwanted harm obsessions of OCD. Those are distressing thoughts a person does not want and will not act on. If you cannot tell which it is, or it feels like more than a thought, treat it as urgent. Get seen the same day.(seek urgent care)
• Not eating or drinking, or skin broken down from washing, because contamination or other fears have taken over basic self-care. This needs medical attention soon.(seek urgent care)
• A sudden swing into unusual energy, racing thoughts, little need for sleep, or reckless behavior, especially soon after starting an antidepressant. This can point to bipolar disorder, which needs a different treatment.(seek urgent care)
• OCD or tics that appear abruptly, almost overnight, in a child after an infection, which is uncommon but worth a prompt medical evaluation.
• Rituals or obsessions taking over an hour a day, or clearly interfering with work, school, relationships, or leaving the house. This is a reason to seek treatment, since effective options exist and it rarely resolves on its own.
• Reassurance-seeking or checking that is escalating, or a fear that is spreading to more of life. This is the pattern that exposure and response prevention treats.

None of this is meant to alarm you. OCD severe enough to disrupt a normal week is a treatable condition with several good options, and reaching for help is the ordinary thing to do.

Common Questions

What is the most effective treatment for OCD?

Exposure and response prevention, a specific form of cognitive behavioral therapy, has the strongest evidence. The SSRI antidepressants work alongside it. Therapy and medication combine well.

Does having violent or sexual intrusive thoughts mean I am dangerous?

No. Unwanted violent, sexual, or religious content is a well-recognized OCD subtype, and it causes distress precisely because it clashes with what the person cares about. The washing, checking, and reassurance-seeking around the thought are the disorder, and exposure-based therapy treats them. An urge you feel you might act on is different, and that is worth getting seen for the same day.

Do I need medication, or is therapy enough?

For many people therapy is enough, and exposure and response prevention remains the single most effective treatment. Medication earns its place in more severe OCD, when therapy is hard to access, or when someone prefers to start there, and the two combine well. With children and teenagers, the usual order is therapy first, then medication for more severe cases. It is an ordinary clinical decision, made with a prescriber.

Do supplements like N-acetylcysteine or myo-inositol help?

The evidence is thin and mixed, and neither is established. The trials for N-acetylcysteine have mostly come back negative, and myo-inositol rests on one small crossover study. The safety risk is low, and both belong alongside proper treatment.

How can family and friends help?

Stop taking part in the rituals, gently. When people close to someone with OCD give repeated reassurance, wait for checks to finish, or rearrange the household around a fear, that is family accommodation. It tends to keep the disorder going and makes it harder to treat. Stepping back from it works best done calmly and with guidance from the therapist, and it is part of the treatment.

Can OCD be cured?

Most people improve a great deal with treatment, and some become symptom-free, though OCD can wax and wane over life and may need attention again during stress. Exposure and response prevention gives people a skill they keep. That is part of why its gains tend to hold.